COVID-19 Vaccine With Patch Delivery Technology Enters Preclinical Testing at UC Davis
By AJ Cheline on April 29, 2020 in Human & Animal Health
Verndari Inc., a biopharmaceutical company, announced today that it will begin preclinical testing this week at UC Davis’ Mouse Biology Program to evaluate a potential vaccine and delivery system for COVID-19.
Verndari’s VaxiPatch is a single-dose vaccination kit that uses a dermal patch with a metal microneedle array to deliver vaccines. The company states that the technology eliminates the need for refrigeration, facilitates high-volume, automated manufacturing of vaccines and can potentially be self-administered on the subject’s arm.
Media Coverage: San Francisco Chronicle